June 3, 2020
Eisai said on June 2 that it introduced its sleep inducer Dayvigo (lemborexant) in the US on June 1 (local time) for the treatment of adults with insomnia characterized by difficulties with sleep onset/sleep maintenance. The drug works as a...read more